{"transactions":[{"id":940485,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-13T21:09:54.000Z","date":"2026-01-09","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third anniversaries of the grant date."}],"balance_after":40000,"derivative":{"exercise_price":1.97,"exercise_date":"2026-01-09","expiration_date":"2036-01-09","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001334549-26-000003","document":"wk-form4_1768338591.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454926000003/wk-form4_1768338591.xml","form_type":"4"}},{"id":940484,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-01-13T21:09:54.000Z","date":"2026-01-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":7854,"price":1.97,"value":15472.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 124,750 unvested restricted stock."}],"balance_after":311890,"source":{"system":"sec-edgar","filing":"0001334549-26-000003","document":"wk-form4_1768338591.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454926000003/wk-form4_1768338591.xml","form_type":"4"}},{"id":940483,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-01-13T21:09:54.000Z","date":"2026-01-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":12224,"price":1.97,"value":24081.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 124,750 unvested restricted stock."}],"balance_after":319744,"source":{"system":"sec-edgar","filing":"0001334549-26-000003","document":"wk-form4_1768338591.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454926000003/wk-form4_1768338591.xml","form_type":"4"}},{"id":940482,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-01-13T21:09:54.000Z","date":"2026-01-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":10515,"price":1.97,"value":20714.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 124,750 unvested restricted stock."}],"balance_after":331968,"source":{"system":"sec-edgar","filing":"0001334549-26-000003","document":"wk-form4_1768338591.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454926000003/wk-form4_1768338591.xml","form_type":"4"}},{"id":940481,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-01-13T21:09:54.000Z","date":"2026-01-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":10503,"price":1.97,"value":20690.91,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 124,750 unvested restricted stock."}],"balance_after":342483,"source":{"system":"sec-edgar","filing":"0001334549-26-000003","document":"wk-form4_1768338591.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454926000003/wk-form4_1768338591.xml","form_type":"4"}},{"id":940480,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-01-13T21:09:54.000Z","date":"2026-01-09","kind":"grant","planned":false,"acquired":true,"shares":81000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 81,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 124,750 unvested restricted stock."}],"balance_after":352986,"source":{"system":"sec-edgar","filing":"0001334549-26-000003","document":"wk-form4_1768338591.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454926000003/wk-form4_1768338591.xml","form_type":"4"}},{"id":1304654,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-13T21:08:40.000Z","date":"2025-01-09","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date."}],"balance_after":40000,"derivative":{"exercise_price":3.8,"exercise_date":"2025-01-09","expiration_date":"2035-01-09","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001334549-25-000002","document":"wk-form4_1736802514.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454925000002/wk-form4_1736802514.xml","form_type":"4"}},{"id":1304653,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-01-13T21:08:40.000Z","date":"2025-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":3106,"price":3.73,"value":11585.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 122,750 unvested restricted stock."}],"balance_after":264690,"source":{"system":"sec-edgar","filing":"0001334549-25-000002","document":"wk-form4_1736802514.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454925000002/wk-form4_1736802514.xml","form_type":"4"}},{"id":1304652,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-01-13T21:08:40.000Z","date":"2025-01-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":7017,"price":3.8,"value":26664.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 129,433 unvested restricted stock."}],"balance_after":267796,"source":{"system":"sec-edgar","filing":"0001334549-25-000002","document":"wk-form4_1736802514.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454925000002/wk-form4_1736802514.xml","form_type":"4"}},{"id":1304651,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-01-13T21:08:40.000Z","date":"2025-01-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":10925,"price":3.8,"value":41515.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 129,433 unvested restricted stock."}],"balance_after":274813,"source":{"system":"sec-edgar","filing":"0001334549-25-000002","document":"wk-form4_1736802514.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454925000002/wk-form4_1736802514.xml","form_type":"4"}},{"id":1304650,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-01-13T21:08:40.000Z","date":"2025-01-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":9414,"price":3.8,"value":35773.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 129,433 unvested restricted stock."}],"balance_after":285738,"source":{"system":"sec-edgar","filing":"0001334549-25-000002","document":"wk-form4_1736802514.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454925000002/wk-form4_1736802514.xml","form_type":"4"}},{"id":1304649,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-01-13T21:08:40.000Z","date":"2025-01-09","kind":"grant","planned":false,"acquired":true,"shares":81000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 81,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 129,433 unvested restricted stock."}],"balance_after":295152,"source":{"system":"sec-edgar","filing":"0001334549-25-000002","document":"wk-form4_1736802514.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454925000002/wk-form4_1736802514.xml","form_type":"4"}},{"id":1395777,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-10-02T21:16:01.000Z","date":"2024-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":26964,"price":2.93,"value":79004.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld as payment of a tax liability on vesting of performance-based stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 107,183 unvested restricted stock."}],"balance_after":211834,"source":{"system":"sec-edgar","filing":"0001334549-24-000006","document":"wk-form4_1727903753.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454924000006/wk-form4_1727903753.xml","form_type":"4"}},{"id":1395776,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-10-02T21:16:01.000Z","date":"2024-10-01","kind":"grant","planned":false,"acquired":true,"shares":58000,"price":2.93,"value":169940.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects 58,000 in performance-based stock units, the criteria for which was satisfied on October 1, 2024 and which vested in full on that same day."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 107,183 unvested restricted stock."}],"balance_after":238798,"source":{"system":"sec-edgar","filing":"0001334549-24-000006","document":"wk-form4_1727903753.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454924000006/wk-form4_1727903753.xml","form_type":"4"}},{"id":1680383,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-01-12T21:02:23.000Z","date":"2024-01-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":1026,"price":2.99,"value":3067.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 107,183 unvested restricted stock."}],"balance_after":174766,"source":{"system":"sec-edgar","filing":"0001334549-24-000004","document":"wk-form4_1705093334.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454924000004/wk-form4_1705093334.xml","form_type":"4"}},{"id":1681160,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-11T21:10:38.000Z","date":"2024-01-09","kind":"grant","planned":false,"acquired":true,"shares":47000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third anniversaries of the grant date."}],"balance_after":47000,"derivative":{"exercise_price":3.08,"exercise_date":"2024-01-09","expiration_date":"2034-01-09","underlying":"Common Stock","underlying_shares":47000},"source":{"system":"sec-edgar","filing":"0001334549-24-000002","document":"wk-form4_1705007427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454924000002/wk-form4_1705007427.xml","form_type":"4"}},{"id":1681159,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-01-11T21:10:38.000Z","date":"2024-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":3470,"price":3,"value":10410.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 109,166 unvested restricted stock."}],"balance_after":175792,"source":{"system":"sec-edgar","filing":"0001334549-24-000002","document":"wk-form4_1705007427.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454924000002/wk-form4_1705007427.xml","form_type":"4"}},{"id":1681158,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-01-11T21:10:38.000Z","date":"2024-01-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":7843,"price":3.08,"value":24156.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 115,850 unvested restricted stock."}],"balance_after":179262,"source":{"system":"sec-edgar","filing":"0001334549-24-000002","document":"wk-form4_1705007427.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454924000002/wk-form4_1705007427.xml","form_type":"4"}},{"id":1681157,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-01-11T21:10:38.000Z","date":"2024-01-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":12203,"price":3.08,"value":37585.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 115,850 unvested restricted stock."}],"balance_after":187105,"source":{"system":"sec-edgar","filing":"0001334549-24-000002","document":"wk-form4_1705007427.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454924000002/wk-form4_1705007427.xml","form_type":"4"}},{"id":1681156,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-01-11T21:10:38.000Z","date":"2024-01-09","kind":"grant","planned":false,"acquired":true,"shares":94000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 94,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 115,850 unvested restricted stock."}],"balance_after":199308,"source":{"system":"sec-edgar","filing":"0001334549-24-000002","document":"wk-form4_1705007427.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454924000002/wk-form4_1705007427.xml","form_type":"4"}},{"id":2054197,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-17T22:05:25.000Z","date":"2023-01-13","kind":"tax_withholding","acquired":false,"shares":397,"price":3.65,"value":1449.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 60,350 unvested restricted stock."}],"balance_after":96543,"source":{"system":"sec-edgar","filing":"0001334549-23-000006","document":"wf-form4_167399310882456.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454923000006/wf-form4_167399310882456.xml","form_type":"4"}},{"id":2056036,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-12T21:02:08.000Z","date":"2023-01-11","kind":"tax_withholding","acquired":false,"shares":1030,"price":3.2,"value":3296.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 61,116 unvested restricted stock."}],"balance_after":96940,"source":{"system":"sec-edgar","filing":"0001334549-23-000004","document":"wf-form4_167355731008270.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454923000004/wf-form4_167355731008270.xml","form_type":"4"}},{"id":2057062,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-01-11T21:07:53.000Z","date":"2023-01-09","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date."}],"balance_after":30000,"derivative":{"exercise_price":3,"exercise_date":"2023-01-09","expiration_date":"2033-01-09","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001334549-23-000002","document":"wf-form4_167347112819363.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454923000002/wf-form4_167347112819363.xml","form_type":"4"}},{"id":2057061,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-11T21:07:53.000Z","date":"2023-01-10","kind":"tax_withholding","acquired":false,"shares":3470,"price":3.195,"value":11086.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 63,100 unvested restricted stock."}],"balance_after":97970,"source":{"system":"sec-edgar","filing":"0001334549-23-000002","document":"wf-form4_167347112819363.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454923000002/wf-form4_167347112819363.xml","form_type":"4"}},{"id":2057060,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-11T21:07:53.000Z","date":"2023-01-09","kind":"tax_withholding","acquired":false,"shares":7845,"price":3,"value":23535.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 69,783 unvested restricted stock."}],"balance_after":101440,"source":{"system":"sec-edgar","filing":"0001334549-23-000002","document":"wf-form4_167347112819363.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454923000002/wf-form4_167347112819363.xml","form_type":"4"}},{"id":2057059,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-11T21:07:53.000Z","date":"2023-01-09","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 60,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 69,783 unvested restricted stock."}],"balance_after":109285,"source":{"system":"sec-edgar","filing":"0001334549-23-000002","document":"wf-form4_167347112819363.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454923000002/wf-form4_167347112819363.xml","form_type":"4"}},{"id":2168395,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-02T20:03:39.000Z","date":"2022-09-01","kind":"tax_withholding","acquired":false,"shares":69742,"price":0.5,"value":34871.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld as payment of a tax liability on vesting of performance rights."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 371,750 of unvested restricted stock."}],"balance_after":739444,"source":{"system":"sec-edgar","filing":"0001334549-22-000007","document":"wf-form4_166214899948261.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454922000007/wf-form4_166214899948261.xml","form_type":"4"}},{"id":2168394,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-02T20:03:39.000Z","date":"2022-09-01","kind":"grant","acquired":true,"shares":150000,"price":0.5,"value":75000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects 150,000 in performance rights, the criteria for which was satisfied on September 1, 2022 and which vested on that same date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 371,750 of unvested restricted stock."}],"balance_after":809186,"source":{"system":"sec-edgar","filing":"0001334549-22-000007","document":"wf-form4_166214899948261.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454922000007/wf-form4_166214899948261.xml","form_type":"4"}},{"id":2434321,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-01-18T21:06:34.000Z","date":"2022-01-14","kind":"tax_withholding","acquired":false,"shares":6611,"price":0.8204,"value":5423.6644,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 371,750 unvested restricted stock."}],"balance_after":631065,"source":{"system":"sec-edgar","filing":"0001334549-22-000004","document":"wf-form4_164253997450422.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454922000004/wf-form4_164253997450422.xml","form_type":"4"}},{"id":2434320,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-01-18T21:06:34.000Z","date":"2022-01-13","kind":"tax_withholding","acquired":false,"shares":6471,"price":0.8063,"value":5217.5673,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 383,500 unvested restricted stock."}],"balance_after":637676,"source":{"system":"sec-edgar","filing":"0001334549-22-000004","document":"wf-form4_164253997450422.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454922000004/wf-form4_164253997450422.xml","form_type":"4"}},{"id":2437226,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-12T21:21:57.000Z","date":"2022-01-10","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date."}],"balance_after":200000,"derivative":{"exercise_price":0.917,"exercise_date":"2022-01-10","expiration_date":"2032-01-10","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001334549-22-000002","document":"wf-form4_164202250108559.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454922000002/wf-form4_164202250108559.xml","form_type":"4"}},{"id":2437225,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-01-12T21:21:57.000Z","date":"2022-01-11","kind":"tax_withholding","acquired":false,"shares":16740,"price":0.8651,"value":14481.774,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 395,000 unvested restricted stock."}],"balance_after":644147,"source":{"system":"sec-edgar","filing":"0001334549-22-000002","document":"wf-form4_164202250108559.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454922000002/wf-form4_164202250108559.xml","form_type":"4"}},{"id":2437224,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-01-12T21:21:57.000Z","date":"2022-01-10","kind":"tax_withholding","acquired":false,"shares":56410,"price":0.917,"value":51727.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 424,750 unvested restricted stock."}],"balance_after":660887,"source":{"system":"sec-edgar","filing":"0001334549-22-000002","document":"wf-form4_164202250108559.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454922000002/wf-form4_164202250108559.xml","form_type":"4"}},{"id":2437223,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-01-12T21:21:57.000Z","date":"2022-01-10","kind":"grant","acquired":true,"shares":401000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 401,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 424,750 unvested restricted stock."}],"balance_after":717297,"source":{"system":"sec-edgar","filing":"0001334549-22-000002","document":"wf-form4_164202250108559.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454922000002/wf-form4_164202250108559.xml","form_type":"4"}},{"id":2739511,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-04-26T23:55:23.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22."},{"field":"security","element":"securityTitle","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22."}],"balance_after":6000,"derivative":{"underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001171843-21-002778","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000117184321002778/ownership.xml","form_type":"4"}},{"id":2906668,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-01-15T21:02:10.000Z","date":"2021-01-14","kind":"tax_withholding","acquired":false,"shares":5936,"price":1.56,"value":9260.16,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 124,000 unvested restricted stock."}],"balance_after":299505,"source":{"system":"sec-edgar","filing":"0001334549-21-000005","document":"wf-form4_161074450975521.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454921000005/wf-form4_161074450975521.xml","form_type":"4"}},{"id":2906667,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-01-15T21:02:10.000Z","date":"2021-01-13","kind":"tax_withholding","acquired":false,"shares":6425,"price":1.55,"value":9958.75,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 135,750 unvested restricted stock."}],"balance_after":305441,"source":{"system":"sec-edgar","filing":"0001334549-21-000005","document":"wf-form4_161074450975521.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454921000005/wf-form4_161074450975521.xml","form_type":"4"}},{"id":2906666,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-01-15T21:02:10.000Z","date":"2021-01-13","kind":"tax_withholding","acquired":false,"shares":21787,"price":1.55,"value":33769.85,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 147,250 unvested restricted stock."}],"balance_after":311866,"source":{"system":"sec-edgar","filing":"0001334549-21-000005","document":"wf-form4_161074450975521.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454921000005/wf-form4_161074450975521.xml","form_type":"4"}},{"id":2906665,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-01-15T21:02:10.000Z","date":"2021-01-13","kind":"grant","acquired":true,"shares":39000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects 39,000 in performance rights, the criteria for which was satisfied on January 13, 2021 and which vested on that same date."}],"balance_after":333653,"source":{"system":"sec-edgar","filing":"0001334549-21-000005","document":"wf-form4_161074450975521.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454921000005/wf-form4_161074450975521.xml","form_type":"4"}},{"id":2910139,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-01-12T23:12:40.000Z","date":"2021-01-11","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date."}],"balance_after":60000,"derivative":{"exercise_price":1.59,"exercise_date":"2021-01-11","expiration_date":"2031-01-11","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001334549-21-000002","document":"wf-form4_161049314731155.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454921000002/wf-form4_161049314731155.xml","form_type":"4"}},{"id":2910138,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-01-12T23:12:40.000Z","date":"2021-01-11","kind":"tax_withholding","acquired":false,"shares":16621,"price":1.59,"value":26427.39,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 147,250 unvested restricted stock."}],"balance_after":294653,"source":{"system":"sec-edgar","filing":"0001334549-21-000002","document":"wf-form4_161049314731155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454921000002/wf-form4_161049314731155.xml","form_type":"4"}},{"id":2910137,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-01-12T23:12:40.000Z","date":"2021-01-11","kind":"grant","acquired":true,"shares":119000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents 119,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 177,000 unvested restricted stock."}],"balance_after":311274,"source":{"system":"sec-edgar","filing":"0001334549-21-000002","document":"wf-form4_161049314731155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454921000002/wf-form4_161049314731155.xml","form_type":"4"}},{"id":2910136,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-01-12T23:12:40.000Z","date":"2021-01-08","kind":"tax_withholding","acquired":false,"shares":4726,"price":1.6,"value":7561.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 58,000 unvested restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."}],"balance_after":192274,"source":{"system":"sec-edgar","filing":"0001334549-21-000002","document":"wf-form4_161049314731155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454921000002/wf-form4_161049314731155.xml","form_type":"4"}},{"id":3180533,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-04-07T21:29:49.000Z","date":"2020-04-03","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21."},{"field":"security","element":"securityTitle","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"N/A"}],"balance_after":6000,"derivative":{"underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001171843-20-002462","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000117184320002462/ownership.xml","form_type":"4"}},{"id":3231380,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-03T23:57:13.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":33500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":33500,"derivative":{"exercise_price":1.29,"exercise_date":"2021-02-28","expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":33500},"source":{"system":"sec-edgar","filing":"0001562180-20-002054","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000156218020002054/primarydocument.xml","form_type":"4"}},{"id":3231379,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-03-03T23:57:13.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Will fully vest on the one-year anniversary of the grant date."}],"balance_after":19000,"derivative":{"exercise_price":0,"exercise_date":"2021-02-28","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001562180-20-002054","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000156218020002054/primarydocument.xml","form_type":"4"}},{"id":3311219,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-01-15T21:05:38.000Z","date":"2020-01-13","kind":"grant","acquired":true,"shares":69000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date."}],"balance_after":69000,"derivative":{"exercise_price":3.28,"exercise_date":"2020-01-13","expiration_date":"2030-01-13","underlying":"Common Stock","underlying_shares":69000},"source":{"system":"sec-edgar","filing":"0001334549-20-000005","document":"wf-form4_157912231463372.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454920000005/wf-form4_157912231463372.xml","form_type":"4"}},{"id":3311218,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-01-15T21:05:38.000Z","date":"2020-01-14","kind":"tax_withholding","acquired":false,"shares":6382,"price":3.38,"value":21571.16,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 66,325 unvested restricted stock awards."}],"balance_after":186382,"source":{"system":"sec-edgar","filing":"0001334549-20-000005","document":"wf-form4_157912231463372.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454920000005/wf-form4_157912231463372.xml","form_type":"4"}},{"id":3311217,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-01-15T21:05:38.000Z","date":"2020-01-13","kind":"tax_withholding","acquired":false,"shares":6246,"price":3.28,"value":20486.88,"ownership":{"direct":true},"balance_after":192764,"source":{"system":"sec-edgar","filing":"0001334549-20-000005","document":"wf-form4_157912231463372.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454920000005/wf-form4_157912231463372.xml","form_type":"4"}},{"id":3311216,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-01-15T21:05:38.000Z","date":"2020-01-13","kind":"grant","acquired":true,"shares":46000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 46,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date."}],"balance_after":199010,"source":{"system":"sec-edgar","filing":"0001334549-20-000005","document":"wf-form4_157912231463372.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454920000005/wf-form4_157912231463372.xml","form_type":"4"}},{"id":3314798,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-01-09T21:04:53.000Z","date":"2020-01-08","kind":"tax_withholding","acquired":false,"shares":4522,"price":2.83,"value":12797.26,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 43,575 unvested restricted stock."}],"balance_after":153010,"source":{"system":"sec-edgar","filing":"0001334549-20-000003","document":"wf-form4_157860387597878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454920000003/wf-form4_157860387597878.xml","form_type":"4"}},{"id":3394285,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Purchase Option","published_at":"2019-10-11T23:27:03.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":10106,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20."},{"field":"security","element":"securityTitle","label":"F3","text":"This amendment is being filed to correct a scrivener's error with regard to the option amount previously reported."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"All exercise prices and share amounts reported in this Form 4/A reflect a 1-for-20 reverse split that occurred on July 17, 2019."},{"field":"shares","element":"transactionShares","label":"F2","text":"All exercise prices and share amounts reported in this Form 4/A reflect a 1-for-20 reverse split that occurred on July 17, 2019."},{"field":"shares","element":"transactionShares","label":"F3","text":"This amendment is being filed to correct a scrivener's error with regard to the option amount previously reported."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20."}],"balance_after":10106,"derivative":{"exercise_price":6.002,"exercise_date":"2019-07-01","expiration_date":"2029-07-01","underlying":"Common Stock","underlying_shares":10106},"source":{"system":"sec-edgar","filing":"0001171843-19-006482","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000117184319006482/ownership.xml","form_type":"4/A","original_submission_date":"2019-07-03"}},{"id":3394261,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-11T22:13:21.000Z","date":"2019-10-09","kind":"exercise","acquired":false,"shares":33333,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.95,"exercise_date":"2019-06-21","expiration_date":"2028-06-21","underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0001562180-19-005150","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000156218019005150/primarydocument.xml","form_type":"4"}},{"id":3394260,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-11T22:13:21.000Z","date":"2019-10-09","kind":"exercise","acquired":true,"shares":33333,"price":1.95,"value":64999.35,"ownership":{"direct":true},"balance_after":200083,"source":{"system":"sec-edgar","filing":"0001562180-19-005150","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000156218019005150/primarydocument.xml","form_type":"4"}},{"id":3418415,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2019-09-10T12:46:30.000Z","date":"2019-09-06","kind":"exercise","acquired":false,"shares":417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On September 6, 2018, the reporting person was granted 417 DSUs. The DSUs vested in full on September 6, 2019 and will be settled solely in shares of the Company's common stock upon the earliest to occur of: (i) the reporting person's termination of service on the Company's Board of Directors and (ii) the occurrence of a \"change in control\" (as defined in the applicable award agreement) that constitutes a \"change in the ownership or effective control of\" the Company or \"a change in the ownership of a substantial portion of the assets of\" the Company, in each case, as determined under Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations issued thereunder."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On September 6, 2018, the reporting person was granted 417 DSUs. The DSUs vested in full on September 6, 2019 and will be settled solely in shares of the Company's common stock upon the earliest to occur of: (i) the reporting person's termination of service on the Company's Board of Directors and (ii) the occurrence of a \"change in control\" (as defined in the applicable award agreement) that constitutes a \"change in the ownership or effective control of\" the Company or \"a change in the ownership of a substantial portion of the assets of\" the Company, in each case, as determined under Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations issued thereunder."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On September 6, 2018, the reporting person was granted 417 DSUs. The DSUs vested in full on September 6, 2019 and will be settled solely in shares of the Company's common stock upon the earliest to occur of: (i) the reporting person's termination of service on the Company's Board of Directors and (ii) the occurrence of a \"change in control\" (as defined in the applicable award agreement) that constitutes a \"change in the ownership or effective control of\" the Company or \"a change in the ownership of a substantial portion of the assets of\" the Company, in each case, as determined under Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations issued thereunder."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":417},"source":{"system":"sec-edgar","filing":"0001562180-19-004701","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000156218019004701/primarydocument.xml","form_type":"4"}},{"id":3418414,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-10T12:46:30.000Z","date":"2019-09-06","kind":"exercise","acquired":true,"shares":417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents vesting of deferred stock units (\"DSUs\") previously awarded to the reporting person, with each deferred stock unit representing the right to receive one share of the common stock of EyePoint Pharmaceuticals, Inc. (the \"Company\")."}],"balance_after":166750,"source":{"system":"sec-edgar","filing":"0001562180-19-004701","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000156218019004701/primarydocument.xml","form_type":"4"}},{"id":3467753,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Purchase Option","published_at":"2019-07-03T21:34:22.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":187510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20."}],"balance_after":187510,"derivative":{"exercise_price":0.3001,"exercise_date":"2019-07-01","expiration_date":"2029-07-01","underlying":"Common Stock","underlying_shares":187510},"source":{"system":"sec-edgar","filing":"0001171843-19-004416","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000117184319004416/ownership.xml","form_type":"4"}},{"id":3476784,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-27T20:52:41.000Z","date":"2019-06-25","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40000,"derivative":{"exercise_price":2.65,"exercise_date":"2020-02-21","expiration_date":"2029-02-21","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001562180-19-003668","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000156218019003668/primarydocument.xml","form_type":"4"}},{"id":3479856,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2019-06-24T20:30:26.000Z","date":"2019-06-21","kind":"exercise","acquired":false,"shares":8333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On June 21, 2018, the reporting person was granted 8,333 DSUs. The DSUs vested in full on June 21, 2019 and will be settled solely in shares of the Company's common stock upon the earliest to occur of: (i) the reporting person's termination of service on the Company's Board of Directors and (ii) the occurrence of a \"change in control\" (as defined in the applicable award agreement) that constitutes a \"change in the ownership or effective control of\" the Company or \"a change in the ownership of a substantial portion of the assets of\" the Company, in each case, as determined under Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations issued thereunder."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 21, 2018, the reporting person was granted 8,333 DSUs. The DSUs vested in full on June 21, 2019 and will be settled solely in shares of the Company's common stock upon the earliest to occur of: (i) the reporting person's termination of service on the Company's Board of Directors and (ii) the occurrence of a \"change in control\" (as defined in the applicable award agreement) that constitutes a \"change in the ownership or effective control of\" the Company or \"a change in the ownership of a substantial portion of the assets of\" the Company, in each case, as determined under Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations issued thereunder."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 21, 2018, the reporting person was granted 8,333 DSUs. The DSUs vested in full on June 21, 2019 and will be settled solely in shares of the Company's common stock upon the earliest to occur of: (i) the reporting person's termination of service on the Company's Board of Directors and (ii) the occurrence of a \"change in control\" (as defined in the applicable award agreement) that constitutes a \"change in the ownership or effective control of\" the Company or \"a change in the ownership of a substantial portion of the assets of\" the Company, in each case, as determined under Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations issued thereunder."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001562180-19-003629","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000156218019003629/primarydocument.xml","form_type":"4"}},{"id":3479855,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-24T20:30:26.000Z","date":"2019-06-21","kind":"exercise","acquired":true,"shares":8333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents vesting of deferred stock units (\"DSUs\") previously awarded to the reporting person, with each deferred stock unit representing the right to receive one share of the common stock of EyePoint Pharmaceuticals, Inc. (the \"Company\")."}],"balance_after":166333,"source":{"system":"sec-edgar","filing":"0001562180-19-003629","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000156218019003629/primarydocument.xml","form_type":"4"}},{"id":3571684,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-01T12:21:34.000Z","date":"2019-03-29","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.77,"exercise_date":"2018-06-27","expiration_date":"2027-06-27","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-19-002054","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000156218019002054/primarydocument.xml","form_type":"4"}},{"id":3571683,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-01T12:21:34.000Z","date":"2019-03-29","kind":"exercise","acquired":true,"shares":20000,"price":1.77,"value":35400.0,"ownership":{"direct":true},"balance_after":158000,"source":{"system":"sec-edgar","filing":"0001562180-19-002054","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000156218019002054/primarydocument.xml","form_type":"4"}},{"id":3695059,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2019-01-16T21:19:41.000Z","date":"2019-01-14","kind":"grant","acquired":true,"shares":71000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date."}],"balance_after":71000,"derivative":{"exercise_price":4.95,"exercise_date":"2019-01-14","expiration_date":"2029-01-14","underlying":"Common Stock","underlying_shares":71000},"source":{"system":"sec-edgar","filing":"0001334549-19-000011","document":"wf-form4_154767356597582.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454919000011/wf-form4_154767356597582.xml","form_type":"4"}},{"id":3695058,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-01-16T21:19:41.000Z","date":"2019-01-14","kind":"tax_withholding","acquired":false,"shares":6301,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 51,900 unvested restricted stock awards."}],"balance_after":151405,"source":{"system":"sec-edgar","filing":"0001334549-19-000011","document":"wf-form4_154767356597582.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454919000011/wf-form4_154767356597582.xml","form_type":"4"}},{"id":3695057,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-01-16T21:19:41.000Z","date":"2019-01-14","kind":"grant","acquired":true,"shares":47000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 47,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date."}],"balance_after":157706,"source":{"system":"sec-edgar","filing":"0001334549-19-000011","document":"wf-form4_154767356597582.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454919000011/wf-form4_154767356597582.xml","form_type":"4"}},{"id":3698606,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-01-10T17:39:51.000Z","date":"2019-01-08","kind":"tax_withholding","acquired":false,"shares":4478,"price":4.64,"value":20777.92,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 16,650 shares of unvested restricted stock."}],"balance_after":110706,"source":{"system":"sec-edgar","filing":"0001334549-19-000008","document":"wf-form4_154714197464567.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000133454919000008/wf-form4_154714197464567.xml","form_type":"4"}},{"id":3820434,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2018-09-10T23:06:57.000Z","date":"2018-09-06","kind":"grant","acquired":true,"shares":417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the right to receive one share of the common stock of EyePoint Pharmaceuticals, Inc. (the \"Company\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subsequent to the vesting of the deferred stock units, the deferred stock units will be settled in shares of the Company's common stock upon the earliest to occur of: (i) the reporting person's termination of service on the Company's Board of Directors and (ii) the occurrence of a \"change in control\" (as defined in the applicable award agreement) that constitutes a \"change in the ownership or effective control of\" the Company or \"a change in the ownership of a substantial portion of the assets of\" the Company, in each case, as determined under Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations issued thereunder."}],"balance_after":417,"derivative":{"exercise_date":"2019-09-06","underlying":"Common Stock","underlying_shares":417},"source":{"system":"sec-edgar","filing":"0000899243-18-024157","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000089924318024157/doc4.xml","form_type":"4"}},{"id":3820433,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-09-10T23:06:57.000Z","date":"2018-09-06","kind":"grant","acquired":true,"shares":1667,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1667,"derivative":{"exercise_price":2.32,"exercise_date":"2019-09-06","expiration_date":"2028-09-06","underlying":"Common Stock","underlying_shares":1667},"source":{"system":"sec-edgar","filing":"0000899243-18-024157","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000089924318024157/doc4.xml","form_type":"4"}},{"id":3880326,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2018-06-29T20:01:13.000Z","date":"2018-06-27","kind":"exercise","acquired":false,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On December 15, 2017, the reporting person was granted 17,500 DSUs. The DSUs vested in full on June 27, 2018 and will be settled solely in shares of the Company's common stock upon the earliest to occur of: (i) the reporting person's termination of service on the Company's Board of Directors and (ii) the occurrence of a \"change in control\" (as defined in the applicable award agreement) that constitutes a \"change in the ownership or effective control of\" the Company or \"a change in the ownership of a substantial portion of the assets of\" the Company, in each case, as determined under Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations issued thereunder."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On December 15, 2017, the reporting person was granted 17,500 DSUs. The DSUs vested in full on June 27, 2018 and will be settled solely in shares of the Company's common stock upon the earliest to occur of: (i) the reporting person's termination of service on the Company's Board of Directors and (ii) the occurrence of a \"change in control\" (as defined in the applicable award agreement) that constitutes a \"change in the ownership or effective control of\" the Company or \"a change in the ownership of a substantial portion of the assets of\" the Company, in each case, as determined under Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations issued thereunder."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On December 15, 2017, the reporting person was granted 17,500 DSUs. The DSUs vested in full on June 27, 2018 and will be settled solely in shares of the Company's common stock upon the earliest to occur of: (i) the reporting person's termination of service on the Company's Board of Directors and (ii) the occurrence of a \"change in control\" (as defined in the applicable award agreement) that constitutes a \"change in the ownership or effective control of\" the Company or \"a change in the ownership of a substantial portion of the assets of\" the Company, in each case, as determined under Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations issued thereunder."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000899243-18-018712","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000089924318018712/doc4.xml","form_type":"4"}},{"id":3880325,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-29T20:01:13.000Z","date":"2018-06-27","kind":"exercise","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents vesting of deferred stock units (\"DSUs\") previously awarded to the reporting person, with each deferred stock unit representing the right to receive one share of the common stock of EyePoint Pharmaceuticals, Inc. (the \"Company\")."}],"balance_after":138000,"source":{"system":"sec-edgar","filing":"0000899243-18-018712","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000089924318018712/doc4.xml","form_type":"4"}},{"id":3882894,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2018-06-26T18:09:41.000Z","date":"2018-06-21","kind":"grant","acquired":true,"shares":8333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the right to receive one share of the common stock of EyePoint Pharmaceuticals, Inc. (the \"Company\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subsequent to the vesting of the deferred stock units, the deferred stock units will be settled in shares of the Company's common stock upon the earliest to occur of: (i) the reporting person's termination of service on the Company's Board of Directors and (ii) the occurrence of a \"change in control\" (as defined in the applicable award agreement) that constitutes a \"change in the ownership or effective control of\" the Company or \"a change in the ownership of a substantial portion of the assets of\" the Company, in each case, as determined under Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations issued thereunder."}],"balance_after":8333,"derivative":{"exercise_date":"2019-06-21","underlying":"Common Stock","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0000899243-18-018093","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000089924318018093/doc4.xml","form_type":"4"}},{"id":3882893,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-06-26T18:09:41.000Z","date":"2018-06-21","kind":"grant","acquired":true,"shares":33333,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":33333,"derivative":{"exercise_price":1.95,"exercise_date":"2019-06-21","expiration_date":"2028-06-21","underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0000899243-18-018093","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000089924318018093/doc4.xml","form_type":"4"}},{"id":3886615,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-06-21T20:22:00.000Z","date":"2018-06-20","kind":"tax_withholding","acquired":false,"shares":16091,"price":8.64,"value":139026.24,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 24,975 shares of unvested restricted stock."}],"balance_after":109453,"source":{"system":"sec-edgar","filing":"0000320017-18-000074","document":"wf-form4_152961250303775.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/320017/000032001718000074/wf-form4_152961250303775.xml","form_type":"4"}},{"id":3886614,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-06-21T20:22:00.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":33300,"price":8.64,"value":287712.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects 33,300 in performance rights, the criteria for which was satisfied on April 6, 2018 and which vested in full on June 20, 2018, when the shareholders voted to approve the new 2018 Equity Incentive Compensation Plan."}],"balance_after":125544,"source":{"system":"sec-edgar","filing":"0000320017-18-000074","document":"wf-form4_152961250303775.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000032001718000074/wf-form4_152961250303775.xml","form_type":"4"}},{"id":3957923,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-04-24T20:00:45.000Z","date":"2018-04-20","kind":"exercise","acquired":false,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.13,"exercise_date":"2009-11-18","expiration_date":"2018-11-18","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0000899243-18-010649","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000089924318010649/doc4.xml","form_type":"4"}},{"id":3957922,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-24T20:00:45.000Z","date":"2018-04-20","kind":"exercise","acquired":true,"shares":120000,"price":1.13,"value":135600.0,"ownership":{"direct":true},"balance_after":120500,"source":{"system":"sec-edgar","filing":"0000899243-18-010649","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000089924318010649/doc4.xml","form_type":"4"}},{"id":3966527,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Rights","published_at":"2018-04-10T22:59:27.000Z","date":"2018-04-06","kind":"grant","acquired":true,"shares":33300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance right represents a contingent right to receive one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The performance criteria was satisfied on April 6, 2018 and the performance right shall vest in full on the date of stockholder approval of a new or amended equity plan provided that such approval is obtained on or prior to August 30, 2018 and if not obtained by such date this performance right shall terminate (the \"Vesting Date\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The performance criteria was satisfied on April 6, 2018 and the performance right shall vest in full on the date of stockholder approval of a new or amended equity plan provided that such approval is obtained on or prior to August 30, 2018 and if not obtained by such date this performance right shall terminate (the \"Vesting Date\")."}],"balance_after":33300,"derivative":{"underlying":"Common Stock","underlying_shares":33300},"source":{"system":"sec-edgar","filing":"0001144204-18-020002","document":"tv490823_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420418020002/tv490823_4.xml","form_type":"4"}},{"id":4102477,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2018-01-10T21:07:04.000Z","date":"2018-01-08","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the shares underlying the stock options vest immediately on the grant date, with an additional one-third vesting on each of the first and second anniversaries of the grant date."}],"balance_after":20000,"derivative":{"exercise_price":3.79,"exercise_date":"2018-01-08","expiration_date":"2028-01-08","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001144204-18-001704","document":"tv483053_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420418001704/tv483053_4.xml","form_type":"4"}},{"id":4102476,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-01-10T21:07:04.000Z","date":"2018-01-08","kind":"tax_withholding","acquired":false,"shares":4462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 67,269 shares of unvested restricted stock."}],"balance_after":92244,"source":{"system":"sec-edgar","filing":"0001144204-18-001704","document":"tv483053_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420418001704/tv483053_4.xml","form_type":"4"}},{"id":4102475,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-01-10T21:07:04.000Z","date":"2018-01-08","kind":"grant","acquired":true,"shares":33300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 33,300 shares of restricted stock granted under the Issuer's 2015 Equity Compensation Plan. The restricted stock vests in three equal installments, with one-third of the shares vesting on the date of grant and an additional one-third vesting on each of the first and second anniversaries of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 67,269 shares of unvested restricted stock."}],"balance_after":96706,"source":{"system":"sec-edgar","filing":"0001144204-18-001704","document":"tv483053_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420418001704/tv483053_4.xml","form_type":"4"}},{"id":4126008,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2017-12-19T21:08:18.000Z","date":"2017-12-15","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the right to receive one share of the common stock of pSivida Corp. (the \"Company\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subsequent to the vesting of the deferred stock units, the deferred stock units will be settled in shares of the Company's common stock upon the earliest to occur of: (i) the reporting person's termination of service on the Company's Board of Directors and (ii) the occurrence of a \"change in control\" (as defined in the applicable award agreement) that constitutes a \"change in the ownership or effective control of\" the Company or \"a change in the ownership of a substantial portion of the assets of\" the Company, in each case, as determined under Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations issued thereunder."}],"balance_after":17500,"derivative":{"exercise_date":"2018-06-27","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000899243-17-029159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000089924317029159/doc4.xml","form_type":"4"}},{"id":4126007,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-12-19T21:08:18.000Z","date":"2017-12-15","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20000,"derivative":{"exercise_price":1.77,"exercise_date":"2018-06-27","expiration_date":"2027-06-27","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-17-029159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000089924317029159/doc4.xml","form_type":"4"}},{"id":4310974,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-05-22T20:30:27.000Z","date":"2017-05-18","kind":"tax_withholding","acquired":false,"shares":17778,"price":5.13,"value":91201.14,"ownership":{"direct":true},"balance_after":56551,"source":{"system":"sec-edgar","filing":"0001144204-17-028886","document":"v467616_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420417028886/v467616_4.xml","form_type":"4"}},{"id":4343981,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-04-27T20:19:40.000Z","date":"2017-04-25","kind":"tax_withholding","acquired":false,"shares":690,"price":4.74,"value":3270.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 36,785 shares of unvested restricted stock."}],"balance_after":74329,"source":{"system":"sec-edgar","filing":"0001144204-17-022656","document":"v465291_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420417022656/v465291_form4.xml","form_type":"4"}},{"id":4479770,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-01-27T22:06:02.000Z","date":"2017-01-25","kind":"tax_withholding","acquired":false,"shares":761,"price":3.87,"value":2945.07,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 38,613 shares of unvested restricted stock."}],"balance_after":75019,"source":{"system":"sec-edgar","filing":"0001144204-17-004362","document":"v457630_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420417004362/v457630_4.xml","form_type":"4"}},{"id":4493445,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2017-01-11T22:50:54.000Z","date":"2017-01-09","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"25% of the shares underlying the stock options vest immediately on the grant date and the remaining 75% of the shares underlying the stock options will vest annually over the following three years."}],"balance_after":50000,"derivative":{"exercise_price":3.54,"exercise_date":"2017-01-09","expiration_date":"2027-01-09","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001144204-17-001862","document":"v456764_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420417001862/v456764_4.xml","form_type":"4"}},{"id":4493444,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-01-11T22:50:54.000Z","date":"2017-01-09","kind":"tax_withholding","acquired":false,"shares":4758,"price":3.54,"value":16843.32,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 39,943 shares of unvested restricted stock."}],"balance_after":75780,"source":{"system":"sec-edgar","filing":"0001144204-17-001862","document":"v456764_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420417001862/v456764_4.xml","form_type":"4"}},{"id":4493443,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-01-11T22:50:54.000Z","date":"2017-01-09","kind":"grant","acquired":true,"shares":33300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 33,300 shares of restricted stock granted under the Issuer's 2015 Equity Compensation Plan. 25% of the shares of restricted stock vest immediately on the grant date and the remaining 75% of the shares of restricted stock will vest annually over the following three years."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 39,943 shares of unvested restricted stock."}],"balance_after":80538,"source":{"system":"sec-edgar","filing":"0001144204-17-001862","document":"v456764_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420417001862/v456764_4.xml","form_type":"4"}},{"id":4521904,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-12-14T17:57:28.000Z","date":"2016-12-12","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":3.49,"exercise_date":"2017-07-21","expiration_date":"2026-07-21","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-16-035511","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000089924316035511/doc4.xml","form_type":"4"}},{"id":4561343,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2016-11-10T21:06:00.000Z","date":"2016-10-25","kind":"tax_withholding","acquired":false,"shares":457,"price":4.12,"value":1882.84,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 15,468 shares of unvested restricted stock."}],"balance_after":47238,"source":{"system":"sec-edgar","filing":"0001144204-16-133276","document":"v452729_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420416133276/v452729_4.xml","form_type":"4"}},{"id":4592352,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69470,"kind":"person","name":"Mazzo David J","position":1,"cik":"0001334549","reported_name":"Mazzo David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2016-09-30T20:31:46.000Z","date":"2016-09-29","kind":"grant","acquired":true,"shares":50919,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These stock options were granted upon the Company's Compensation Committee approval on September 29, 2016, in consideration of the unpaid portion of the reporting person's discretionary 2015 target bonus."}],"balance_after":50919,"derivative":{"exercise_price":4.77,"exercise_date":"2016-09-29","expiration_date":"2026-09-29","underlying":"Common Stock","underlying_shares":50919},"source":{"system":"sec-edgar","filing":"0001144204-16-126313","document":"v449792_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420416126313/v449792_4.xml","form_type":"4"}}]}